Publications by authors named "Scott D Bercury"

Claim this Profile
S
Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.
Mario A Cabrera-Salazar, Matthew Deriso, Scott D Bercury, Lingyun Li, John T Lydon

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
Karen M Ashe, Dinesh Bangari, Lingyun Li, Mario A Cabrera-Salazar, Scott D Bercury

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion.
Robin J Ziegler, Ernesto A Salegio, James C Dodge, John Bringas, Christopher M Treleaven, Scott D Bercury

Exp Neurol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy.
Gregory D Hurlbut, Robin J Ziegler, Jennifer B Nietupski, Joseph W Foley, Lisa A Woodworth, Scott D Bercury

Mol Ther· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and improve motor function in Pompe mice.
Joseph W Foley, Scott D Bercury, Patrick Finn, Seng H Cheng, Ronald K Scheule

Mol Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease.
Yunxiang Zhu, Ji-Lei Jiang, Nathan K Gumlaw, Jinhua Zhang, Scott D Bercury

Mol Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice.
Robin J Ziegler, Scott D Bercury, Jonathan Fidler, Michael A Zhao, Joseph Foley

Hum Gene Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A.
Robin J Ziegler, Maribeth Cherry, Christine M Barbon, Chester Li, Scott D Bercury

Mol Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8-mediated Hepatic Expression of α-galactosidase A.
Robin J Ziegler, Maribeth Cherry, Christine M Barbon, Chester Li, Scott D Bercury

Mol Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Andrew M Tager, Richard L Kradin, Peter LaCamera, Scott D Bercury, Gabriele S V Campanella

Am J Respir Cell Mol Biol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment.
Andrew M Tager, Shannon K Bromley, Benjamin D Medoff, Sabina A Islam, Scott D Bercury

Nat Immunol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis